Journal of Parkinsons Disease

Papers
(The H4-Index of Journal of Parkinsons Disease is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists121
Clinical Trial Highlights: Modulators of Mitochondrial Function96
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention77
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease64
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?62
A framework to standardize gait study protocols in Parkinson's disease61
A Multisensory Deficit in the Perception of Pleasantness in Parkinson’s Disease52
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression52
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?50
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review50
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease50
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease48
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease45
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative44
Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling43
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”42
What medicines do people with Parkinson's disease want?42
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort41
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”40
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients40
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease39
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease39
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease38
The fixel GI Parkinson's research and integrated support model (PRISM)38
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease37
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis36
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders35
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy33
Are Preformed Fibrils a Model of Parkinson’s Disease?32
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease31
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease31
0.26836609840393